A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points
The TKO approach potentiates early imaging of rituximab radioimmunoconjugates and has translational potential for lymphoma imaging.
Authors
- Kexiang Xu (ORCID: https://orcid.org/0000-0003-4607-4040)
- Jonathan M. Pham (ORCID: https://orcid.org/0000-0002-4617-5143)
- Anna King (ORCID: https://orcid.org/0000-0002-8708-8601)
- Nitika Sharma (ORCID: https://orcid.org/0000-0001-5323-3180)
- Andres Fernandez del Castillo (ORCID: https://orcid.org/0000-0002-1139-5760)
- Kimberly J. Edwards (ORCID: https://orcid.org/0000-0002-9549-0182)
- Mark A. Sellmyer (ORCID: https://orcid.org/0000-0002-1407-1905)
- Michael D. Farwell (ORCID: https://orcid.org/0000-0003-0650-4747)
- Daniel A. Pryma (ORCID: https://orcid.org/0000-0001-8978-4419)
- Stephen J. Schuster (ORCID: https://orcid.org/0000-0002-3376-8978)
- Swarbhanu Sarkar
Institutions
- University of Pennsylvania (US)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1186/s13550-025-01213-x
- Citations
- 2
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- Burroughs Wellcome Fund
- Cancer Research Institute